WO2004020592A3 - Vaccination genetique retrocanalaire par l'intermediaire des glandes salivaires - Google Patents
Vaccination genetique retrocanalaire par l'intermediaire des glandes salivaires Download PDFInfo
- Publication number
- WO2004020592A3 WO2004020592A3 PCT/US2003/026872 US0326872W WO2004020592A3 WO 2004020592 A3 WO2004020592 A3 WO 2004020592A3 US 0326872 W US0326872 W US 0326872W WO 2004020592 A3 WO2004020592 A3 WO 2004020592A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- retroductal
- salivary gland
- genetic vaccination
- methods
- vaccination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003262922A AU2003262922A1 (en) | 2002-08-30 | 2003-08-26 | Retroductal salivary gland genetic vaccination |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40737502P | 2002-08-30 | 2002-08-30 | |
US60/407,375 | 2002-08-30 | ||
US45399903P | 2003-03-11 | 2003-03-11 | |
US60/453,999 | 2003-03-11 | ||
US63993503A | 2003-08-12 | 2003-08-12 | |
US10/639,935 | 2003-08-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004020592A2 WO2004020592A2 (fr) | 2004-03-11 |
WO2004020592A3 true WO2004020592A3 (fr) | 2004-08-12 |
Family
ID=31982347
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/026872 WO2004020592A2 (fr) | 2002-08-30 | 2003-08-26 | Vaccination genetique retrocanalaire par l'intermediaire des glandes salivaires |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003262922A1 (fr) |
WO (1) | WO2004020592A2 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2538007T3 (es) | 2009-09-16 | 2015-06-16 | Vaxart, Inc. | Estrategia de inmunización para prevenir una infección por H1N1 |
EP3107568B1 (fr) | 2014-02-20 | 2024-03-27 | Vaxart, Inc. | Formulations pour administration dans l'intestin grêle |
US11433146B2 (en) | 2015-06-12 | 2022-09-06 | Vaxart, Inc. | Formulations for small intestinal delivery of RSV and norovirus antigens |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5593972A (en) * | 1993-01-26 | 1997-01-14 | The Wistar Institute | Genetic immunization |
US5744460A (en) * | 1996-03-07 | 1998-04-28 | Novartis Corporation | Combination for treatment of proliferative diseases |
US5962429A (en) * | 1996-11-22 | 1999-10-05 | University Of Iowa | Complexes of adenovirus with cationic molecules |
US6004944A (en) * | 1995-03-24 | 1999-12-21 | The Regents Of The University Of California | Protein delivery by secretory gland expression |
US6372722B1 (en) * | 2000-01-19 | 2002-04-16 | Genteric, Inc. | Method for nucleic acid transfection of cells |
-
2003
- 2003-08-26 WO PCT/US2003/026872 patent/WO2004020592A2/fr not_active Application Discontinuation
- 2003-08-26 AU AU2003262922A patent/AU2003262922A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5593972A (en) * | 1993-01-26 | 1997-01-14 | The Wistar Institute | Genetic immunization |
US6004944A (en) * | 1995-03-24 | 1999-12-21 | The Regents Of The University Of California | Protein delivery by secretory gland expression |
US5744460A (en) * | 1996-03-07 | 1998-04-28 | Novartis Corporation | Combination for treatment of proliferative diseases |
US5962429A (en) * | 1996-11-22 | 1999-10-05 | University Of Iowa | Complexes of adenovirus with cationic molecules |
US6372722B1 (en) * | 2000-01-19 | 2002-04-16 | Genteric, Inc. | Method for nucleic acid transfection of cells |
Also Published As
Publication number | Publication date |
---|---|
AU2003262922A8 (en) | 2004-03-19 |
WO2004020592A2 (fr) | 2004-03-11 |
AU2003262922A1 (en) | 2004-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002081646A3 (fr) | Sequences d'epitopes | |
WO2004022709A3 (fr) | Sequences de sites antigeniques | |
WO2005037190A3 (fr) | Vaccins multiplex | |
NZ532665A (en) | Neisseria meningitidis antigens and compositions | |
WO2005002621A3 (fr) | Methodes visant a eliciter, ameliorer et maintenir des reponses immunitaires dirigees contre des epitopes restreints du cmh de classe i, a des fins prophylactiques ou therapeutiques | |
WO2006017856A3 (fr) | Procedes de production de vaccins non antibioresistants | |
WO2001034801A3 (fr) | Vaccins contenant de la gelatine recombinante | |
WO2004093808A3 (fr) | Nouveaux antigenes associes a une tumeur | |
WO2005032582A3 (fr) | Compositions immunogènes pour streptococcus pyogenes | |
WO2006081007A3 (fr) | Utilisation de flagelline en immunotherapie antitumorale | |
TW200515916A (en) | Chimeric antigens for breaking host tolerance to foreign antigens | |
WO2003026691A3 (fr) | Procede | |
WO2006055024A3 (fr) | Minicellules employees comme vaccins | |
AU2003244855A1 (en) | Method to enhance an immune response of nucleic acid vaccination | |
WO2008130382A3 (fr) | Protéines de fusion à base de cytokine pour le traitement de troubles immunitaires | |
WO2003072746A3 (fr) | Proteines de la subtilisine (carlsberg) presentant une antigenicite reduite | |
ATE551069T1 (de) | Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung | |
WO2005000884A8 (fr) | Conjugues d'acide poly-gamma-glutamique pour solliciter des reponses immunitaires dirigees contre des bacilles | |
WO2001074855A3 (fr) | Cellule dendritique compositions et methodes pour immunotherapie a base de cellules dendritiques | |
AU2003248150A1 (en) | Exosome containing exogenous antigen through gene transfection and method for utilizing the same | |
AU2002242175A1 (en) | Methods for modulating an immune response by modulating the interaction between ctla4 and pp2a | |
WO2004020592A3 (fr) | Vaccination genetique retrocanalaire par l'intermediaire des glandes salivaires | |
WO2001074845A3 (fr) | Peptides immunogenes derives d'antigene d'enveloppe specifique de la prostate (psma) et leur utilisation | |
WO2004032599A3 (fr) | Nouvelles proteines immunogenes de leptospira | |
AU2002365269A1 (en) | Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |